Gert J Ossenkoppele

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Bob Löwenberg, Carlos Graux, Nancy Boeckx, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B‐cell lymphoma

C. Meijer, G. Ossenkoppele, J. Muris, 2006, Hematological oncology.

Cytarabine dose for acute myeloid leukemia.

Augustin Ferrant, Bob Löwenberg, Alois Gratwohl, 2011, The New England journal of medicine.

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Torsten Haferlach, Claude Preudhomme, Wolfgang Kern, 2018, Blood.

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Bob Löwenberg, Benjamin L Ebert, Pierre Fenaux, 2017, Blood.

Review Articles (434 articles)

Bob Löwenberg, Pierre Fenaux, Hartmut Döhner, 2008 .

Prognostic index for adult patients with acute myeloid leukemia in first relapse.

Bob Löwenberg, E. Vellenga, G. Ossenkoppele, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.

Bob Löwenberg, Ruud Delwel, P. Sonneveld, 2003, Blood.